Vactosertib Uses, Dosage, Side Effects and more
Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Vactosertib |
| Generic | Vactosertib |
| Vactosertib Other Names | Vactosertib |
| Type | |
| Formula | C22H18FN7 |
| Weight | Average: 399.433 Monoisotopic: 399.160771771 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
